Trials / Sponsors / Khondrion BV
Khondrion BV
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Disease Mitochondrial Diseases, Maternally Inherited Diabetes and Deafness (MIDD), Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS) | Phase 3 | 2026-02-01 |
| Completed | The KHENEREXT Study Mitochondrial Diseases, Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation, Maternally Inherited Diabetes and Deafness (MIDD) | Phase 2 | 2021-08-09 |
| Suspended | The KHENERGYC Study Mitochondrial Diseases, Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation, MELAS | Phase 2 | 2021-02-01 |
| Completed | The KHENERGYZE Study Mitochondrial Diseases, Mitochondrial Myopathies, Mitochondrial Encephalomyopathies | Phase 2 | 2019-10-30 |
| Completed | The KHENERGY Study Mitochondrial Diseases, Mitochondrial Myopathies, Mitochondrial Encephalomyopathies | Phase 2 | 2016-09-01 |
| Completed | A Dose-escalating Clinical Trial With KH176 MELAS, LHON, Leigh Syndrome | Phase 1 | 2015-05-01 |